ArticleOncogene2015
Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance.
R I Cordo Russo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this papercites it